Next EUROSON Congress
Euroson 2017 Congress is six months ahead and the preliminary programme is on the website http://www.euroson2017.org. Abstract submission is already available.
This year, the congress will be running in 5 parallel meeting halls covering a great variety of topics in ultrasound: US-guided interventions, pediatrics, emergency, breast, musculoskeletal will be covered widely and interactively. New guidelines will also be discussed in detail.
Those who are interested in obstetrics or thyroid US will have the chance to participate in full-coverage structured condensed categorical courses. In these courses, ex-perts will not only present their theoretical knowledge, but will also share their practical experiences with interactive practical demos. Abdominal and gastroenterological US sessions will be plentiful with all tips and tricks about the use of elastography and contrast agents for abdominal organs and the gastrointestinal tract.
Furthermore, medical students will become familiar with the spectrum of sonography. Hands-on training with experts in the Ultra-sound Learning Center (ULC) will also be available for all students and of course for all other participants.
Participants can be more active by sending their scientific works in several forms (oral-poster and video-case presentations), to be presented within the major sessions, if selected. Please, forward abstracts before 21 April.
Beyond the scientific content, a congress is expected to offer an enjoyable social atmosphere. Ljubljana is certainly an excellent city to create this warm environment. We are looking forward to meeting you in Ljubljana, Slovenia Friday 22- Sunday 24 September.
Prof. Dr. Odd Helge Gilja, EFSUMB President
Prof. Dr. Adnan Kabaalioğlu, EUROSON Congress 2017 President
Prof. Dr. Mustafa Seçil, Chairman Local Organising Committee
Prizes to be won at EUROSON 2017
EFSUMB offers an annual 500 euro prize for the best published paper, that is an original article published in a journal up to three years before EUROSON 2017. The EFSUMB member’s National Society should propose up to two articles as soon as possible. All the details of the criteria for consideration are listed on the EFSUMB website under the Research heading.
If you are under 39 years of age and are nominated by your National Society you can have the chance to win the Young Investigator Award prize at EUROSON 2017 Ljubljana, Slovenia, which has been increased to 3000 euro. The prize money can be divided between the best technical and clinical presentation.
The Walter Krienitz Society offers an annual prize of 500 euro for the best oncological abstract submitted to a EUROSON Congress. The abstracts will be considered by a specially appointed jury of EFSUMB Committee members to evaluate the best paper.
If you missed our webinar on Paediatric CEUS you can visit the EFSUMB website to view it in the archive section. Our next webinar will take place on 4 May at 18.00 CET on how to perform CEUS with lectures from Prof Fabio Piscaglia on Clinical pre-requisites and Prof Christoph F Dietrich offering Tips and Tricks.
Elasto liver guidelines
This is the first update of the 2013 EFSUMB Guidelines and Recommendations on the clinical use of elastography, focused on the assessment of diffuse liver disease. The first part (long version) deals with the basic principles of elastography and provides an update of how the technology has changed. The practical advantages and disadvantages
associated with each of the techniques are described, and guidance is provided regarding optimization of scanning technique, image display, image interpretation, reporting of data and some of the known image artifacts. The second part provides clinical information about the practical use of elastography equipment and the interpretation of results in the assessment of diffuse liver disease and analyzes the main findings based on published studies, stressing the evidence from meta-analyses.
The role of elastography in different etiologies of liver disease and in several clinical scenarios is also discussed. All of the recommendations are judged with regard to their evidence-based strength according to the Oxford Centre for Evidence-Based Medicine Levels of Evidence. This updated document is intended to act as a reference and to provide a practical guide for both beginners and advanced clinical users.